Dr Agarwal's Health Care Faces Market Challenges Amid Decreased Investor Participation

Dr Agarwal's Health Care has experienced notable activity today, reflecting a challenging market environment. As of February 27, 2025, the stock has seen a percentage change of -0.68% from its issue price and a slight increase of 0.59% from its listing price. However, it underperformed its sector by 1.66%, with a day’s low of Rs 395.2, marking a decline of 2.41%.
The stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Additionally, investor participation has decreased, with a delivery volume of 3.52 lakh shares on February 25, down 13.88% from the 5-day average. Despite this, the stock remains liquid enough for trades sized at Rs 0.64 crore, based on 2% of the 5-day average traded value.

In terms of quality, Dr Agarwal's Health Care is rated as average compared to its peers, such as Rainbow Children's Hospital and Vijaya Diagnostic, which are rated as good. Valuation metrics indicate that Dr Agarwal's is considered very expensive, with a P/E ratio of 154.004, compared to its peers, which also reflect high valuation levels.